Skip to content
NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP

Smith & Nephew PLC SNN

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$6.2B
▲ 6.1% YoY
$625.0M
▲ 51.7% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 6.2B
Revenue, FY2025 · full 11-year series below
Revenue $B Net income $B
FY2025 · Revenue 6.2 · Net income 0.6
2.5B5.0B
20152018202120242025
Compound annual growth
+5.7%
+6.2%
+2.9%
+41.0%
+6.9%
+4.3%
+41.1%
+6.9%
+4.6%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +6.2% a year over the five years to FY2025 — but profit grew faster: net income at +6.9%, earnings per share at +6.9%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

10 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 12.9% · Net 10.1%
5%10%15%
201520202025
ROE
FY2025 · ROE 11.8%
5%10%15%
201520202025
Three returns, three denominators.

Each USD of equity produced 12 cents of profit this year.

Cash & shareholders

USD 502.0M
returned in FY2025 · dividends + net buybacks
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 502.0
200M400M
20152016201720182019202020222025

USD 502.0M in buybacks — 80% of the year's profit went back to shareholders.

Total assetsUSD 10.5B
EquityUSD 5.3B
CashUSD 557.0M
Gross debtUSD 3.1B
Net debtUSD 2.6B
Current ratio2.57×

Net debt stands at 48% of equity.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
SNN, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B6.25.85.55.25.24.65.14.94.84.74.6
Operating income $B0.80.70.40.50.60.30.80.90.90.80.6
EBITDA $B◌◌0.60.70.80.51.01.01.41.21.1
Income tax $B0.20.10.00.00.1−0.20.10.10.10.30.1
Net income $B0.60.40.30.20.50.40.60.70.80.80.4
EPS, diluted $0.720.470.300.260.600.510.6075.700.880.880.46
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————
ROE %11.87.95.04.19.78.612.013.917.819.810.3

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 1 failure in 54 reconciliationsAUDITED

Reconciled in 10 of the 11 fiscal years we could check. 16 checks were skipped: the balance sheet is not tagged before 2015. Eight checks were skipped: EPS is not tagged before 2015. Eight checks were skipped: revenue is not tagged before 2015.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency1 failure
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNYSE
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2015

Share this section

Download image